Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
SMURF2 inhibits autophagic control of Mycobacterium tuberculosis in macrophages
Priscila C. Campos, Kathryn C. Rahlwes, Victoria A. Ektnitphong, Beatriz R.S. Dias, Kubra F. Naqvi, Samuel Alvarez-Arguedas, Michael U. Shiloh
Priscila C. Campos, Kathryn C. Rahlwes, Victoria A. Ektnitphong, Beatriz R.S. Dias, Kubra F. Naqvi, Samuel Alvarez-Arguedas, Michael U. Shiloh
View: Text | PDF
Research Article Immunology Infectious disease Microbiology

SMURF2 inhibits autophagic control of Mycobacterium tuberculosis in macrophages

  • Text
  • PDF
Abstract

Autophagy is a critical host defense mechanism that restricts intracellular pathogens such as Mycobacterium tuberculosis. A key step in this process is the ubiquitination of M. tuberculosis or M. tuberculosis–associated structures. The E3 ligase Smad-specific E3 ubiquitin protein ligase 1 (SMURF1) catalyzes K48-linked ubiquitination, promoting bacterial clearance. However, the function of its homolog, SMURF2, in host defense remains undefined. Here, we demonstrate that Smurf2 deletion in murine macrophages increases SMURF1 levels, enhances LC3B lipidation, augments K48 ubiquitination of M. tuberculosis–associated structures, and reduces intracellular M. tuberculosis replication. These effects are reversed by Smurf1 deletion, supporting a role for SMURF1 in SMURF2-dependent control of M. tuberculosis. Mice with myeloid-specific Smurf2 deletion exhibit modestly prolonged survival after aerosol M. tuberculosis infection. In human macrophages, SMURF2 knockdown or its pharmacological inhibition with the HECT E3-ligase inhibitor Heclin reduces M. tuberculosis replication. Together, our findings identify SMURF2 as a negative regulator of macrophage control of M. tuberculosis and support further investigation of SMURF2 as a potential target for host-directed therapy in tuberculosis.

Authors

Priscila C. Campos, Kathryn C. Rahlwes, Victoria A. Ektnitphong, Beatriz R.S. Dias, Kubra F. Naqvi, Samuel Alvarez-Arguedas, Michael U. Shiloh

×

Figure 6

LysMCre+/–Smurf2fl/fl murine macrophages are more resistant to M. tuberculosis infection.

Options: View larger image (or click on image) Download as PowerPoint

LysMCre+/–Smurf2fl/fl murine macrophages are more resistant to M. tuber...
(A) CFUs of M. tuberculosis in Smurf2fl/fl and LysMCre+/–Smurf2fl/fl BMDMs at different time points after infection (ns, nonsignificant, and ***P < 0.001; 2-way ANOVA). (B) Representative immunoblot analysis showing SMURF2, SMURF1, and LC3B lipidation levels in protein lysates from Smurf2fl/fl and LysMCre+/–Smurf2fl/fl BMDMs, 24 hours after infection. (C–E) Densitometric quantification of SMURF2, SMURF1, and LC3B-II levels as shown in B, from 3 independent experiments (mean ± SD of 3 independent experiments, ns, nonsignificant, **P < 0.01 and ****P < 0.0001; 2-way ANOVA). (F) Representative immunofluorescence images of M. tuberculosis–mCherry (red) with LC3B (green) in Smurf2fl/fl and LysMCre+/–Smurf2fl/fl BMDMs, using anti-LC3B antibody 17 hours after infection. (G) Quantification of M. tuberculosis–mCherry (red) colocalization with LC3B (green) as shown in F (mean ± SD of 3 independent experiments, performed in triplicate, ns, nonsignificant; unpaired t test). Scale bar: 5 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts